EC Number   |
Application |
Reference |
|---|
    1.1.1.21 | biotechnology |
ALDRXV4 gene from Xerophyta viscosa is a potential candidate for developing stress-tolerant crop plants |
739042 |
| 1.1.1.21 | biotechnology |
use of enzyme in production of xylitol from bagasse hydrolysate, enzyme activity is higher in medium containing acetic acid than in control medium |
654318 |
| 1.1.1.21 | diagnostics |
AKR1B10 may have a potential role as a tumor marker |
712014 |
| 1.1.1.21 | drug development |
development of reductase inhibitors as drugs counteracting the onset of diabetic complications |
737763 |
| 1.1.1.21 | drug development |
homochiral 3-hydroxy-4-substituted beta-lactams serve as precursors to the corresponding alpah-hydroxy-beta-amino acids, the enzyme might be useful insynthesis of these key components of many biologically and therapeutically important compounds |
670920 |
| 1.1.1.21 | drug development |
the enzyme is a target for inhibitor design, enzyme inhibition has considerable potential for the treatment of diabetes, without increased risk of hypoglycemia |
669030 |
| 1.1.1.21 | drug development |
the enzyme may be a potential drug target or vaccine candidate for schistosomes |
723337 |
| 1.1.1.21 | medicine |
aldose reductase ALR2 is a target enzyme for the treatment of diabetic complications |
711904 |
| 1.1.1.21 | medicine |
ALR2 is a critical target to prevent and control diabetic complications through the inhibition of its activity |
697496 |
| 1.1.1.21 | medicine |
enzyme protein levels and activity decrease progressively during heart failure upon rapid left ventricular pacing, such as myocardial capacity to detoxify lipid-peroxidation derived aldehydes |
654170 |
